Daniele Chaves-Moreira, PhD
Dr. Daniele Moreira is a PostDoc researcher with the Ovarian Cancer Research Center at the University of Pennsylvania. She is a Pharmacist and Biochemist with deep experience in Molecular and Cell Biology acquired during her Masters and PhD. Her first contact with cancer research was at the Johns Hopkins University in the Department of Biophysics and Biophysical Chemistry. During her training in new drug design she was mentored by Dr. Mario Amzel and Dra. Sandra Gabelli in a collaborative project with Dr. Bert Vogelstein. Her scientific interests are the strategies for cancer early detection, diagnosis, prognostic and new drug discovery. Nowadays, Dr. Moreira is focusing on ovarian cancer research under the supervision of the experienced researcher Dr. Ronny Drapkin. Her ultimate goal is to determine how the transcription factor, PAX8 regulates expression of its target genes and how PAX8-interacting proteins influence that function. The inhibition of those protein-protein interactions may provide novel avenues to abrogate PAX8 function and might bring implications for ovarian cancer new drug discovery. The support from the OCRA will equip her with the tools to pursue an independent research career dedicated to prevent, treat and defeat ovarian cancer.